As per the findings of the research, based on products, the SPECT is the largest category, in the global nuclear imaging equipment market. Hybrid SPECT, further forms the larger part of the global market for SPECT. Oncology has been the largest application of the global market, followed by cardiology, neurology and others. Hospitals has been the largest end user of nuclear imaging equipment, followed by diagnostic centers, research institutes and others.
Download Report Sample at: https://www.psmarketresearch.com/market-analysis/nuclear-imaging-equipment-market/report-sample
Globally, the increasing prevalence of cancer and cardiovascular disease has been playing a key role in the growth of the nuclear imaging equipment market. The rapidly increasing burden of cancer is leading to increase in demand for oncology services, which further compels government organizations and healthcare providers to provide improved facilities for effective disease diagnosis and treatment.
The increasing burden of cardiovascular diseases is expected to result in higher death rates and additional economic cost. Thus, several developments have been taking place for efficient disease diagnosis and treatment, leading to high adoption rate of nuclear imaging equipment, globally.
Some of the key players in the global nuclear imaging equipment market include Siemens AG, GE Healthcare, Philips Healthcare, Digirad Corporation and Neusoft Medical Systems Co., Ltd., Cannon Inc., DDD Diagnostics, CMR Naviscan Corporation, SurgicEye GmbH and Mediso Medical Imaging Systems Ltd.
About P&S Intelligence
P&S Intelligence is a provider of market research and consulting services catering to the market information needs of burgeoning industries across the world. Providing the plinth of market intelligence, P&S as an enterprising research and consulting company, believes in providing thorough landscape analyses on the ever-changing market scenario, to empower companies to make informed decisions and base their business strategies with astuteness.
Toll-free: +1-888-778-7886 (USA/Canada)
Email: [email protected]
This post was originally published on Financial Sector